Press "esc" to clear
Go to Advanced Search

Showing results

3140 of 5454
  • Embargo expired:
    18-Jun-2018 11:00 AM EDT

Article ID: 696044

Faster, Cheaper, Better: A New Way to Synthesize DNA

Lawrence Berkeley National Laboratory

Researchers at the Department of Energy’s Joint BioEnergy Institute (JBEI) based at Berkeley Lab have pioneered a new way to synthesize DNA sequences through a creative use of enzymes that promises to be faster, cheaper, and more accurate. DNA synthesis is a fundamental tool in the rapidly growing field of synthetic biology, in which organisms can be engineered to do things like decompose plastic and manufacture biofuels and medicines. This discovery could dramatically accelerate the pace of scientific discovery.

Released:
14-Jun-2018 11:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
SEM-TEM-nanoparticle-scale-bars.jpg
  • Embargo expired:
    18-Jun-2018 11:00 AM EDT

Article ID: 696106

Scientists Create Continuously Emitting Microlasers With Nanoparticle-Coated Beads

Lawrence Berkeley National Laboratory

Researchers have found a way to convert nanoparticle-coated microscopic beads into lasers smaller than red blood cells. These microlasers, which convert infrared light into light at higher frequencies, are among the smallest continuously emitting lasers of their kind ever reported and can constantly and stably emit light for hours at a time, even when submerged in biological fluids such as blood serum.

Released:
14-Jun-2018 1:50 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696190

American Neurological Association to feature groundbreaking science and cell-based therapies at 143rd Annual Meeting October 21-23, 2018 in Atlanta

American Neurological Association (ANA)

The American Neurological Association (ANA), the professional organization representing the nation’s top academic neurologists and neuroscientists, will host its 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta. More than 800 of the nation’s top academic neurologists as well as students, trainees, and international professionals will convene for three days of research at the vanguard of neurology and neuroscience.

Released:
18-Jun-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
artwork_s_layer_final.jpg

Article ID: 696209

SLAC, Stanford Scientists Discover How a Hardy Microbe’s Crystalline Shell Helps it Reel in Food

SLAC National Accelerator Laboratory

SLAC and Stanford scientists have discovered how some archaea thrive where other organisms would starve: Their crystalline shells not only protect them from the environment, but they also draw in nutrients through nanosized pores. Those nutrients concentrate in the space between the shell and the microbial cell, so what looks like a famine turns into a feast.

Released:
18-Jun-2018 12:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Cortes.jpg
  • Embargo expired:
    16-Jun-2018 2:30 AM EDT

Article ID: 696175

Phase III study shows quizartinib prolongs overall survival for patients with deadly type of relapsed or refractory AML

University of Texas M. D. Anderson Cancer Center

A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML) linked to a genetic mutation called FMS-like internal tandem duplications (FLT3-ITD).

Released:
15-Jun-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Joan_Lappe.jpg

Article ID: 696191

New study shows higher vitamin D levels could lower risk for breast cancer

Creighton University

This study found that women with a blood level of >60 ng/ml had an 80 percent lower risk for breast cancer than those with levels of 20 ng/ml or less.

Released:
15-Jun-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
061518_vitamin_d_capsules_pixabay.jpg

Article ID: 696177

Greater Levels of Vitamin D Associated with Decreasing Risk of Breast Cancer

University of California San Diego Health

Researchers at University of California San Diego School of Medicine suggest higher levels of vitamin D are associated with decreasing risk of breast cancer. Their epidemiological study is published in the June 15 online issue of PLOS ONE, in collaboration with Creighton University, Medical University of South Carolina and GrassrootsHealth, an Encinitas-based nonprofit organization that promotes vitamin D research and its therapeutic benefits.

Released:
15-Jun-2018 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696116

Can Less Treatment be as Effective for Anal Cancer?

Diseases of the Colon and Rectum Journal

The incidence of anal cancer continues to rise. Despite making the headlines with Farrah Fawcett, people are still reluctant to discuss this important cancer. The majority of patients with this cancer are cured by a combination of treatment of radiation and chemotherapy.

Released:
15-Jun-2018 11:20 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696178

Temple University Scientists Eradicate Cancer Cells Through Dual Targeting of DNA Repair Mechanisms

Temple University

Proteins commonly known as BRCA – short for BReast CAncer susceptibility gene– serve a critical role in cellular DNA repair, but when mutated they allow genetic errors to replicate, facilitating cancer development. If the BRCA repair system is disabled in cancer cells, the cells simply turn to backup repair mechanisms and adapt to alternative repair pathways, a survival mode that also underlies their ability to evade targeted drug therapies.

Released:
15-Jun-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696093

American Society for Radiation Oncology (ASTRO) to host 60th Annual Meeting in San Antonio, October 21-24

American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) will host its 60th Annual Meeting at the Henry B. Gonzalez Convention Center in San Antonio, October 18-24, 2018. The meeting will feature updates from clinical trials and cancer research involving radiation therapy, and keynote addresses from Ned Sharpless, MD, Director of the National Cancer Institute and Yukiya Amano, Director General of the International Atomic Energy Agency .

Released:
14-Jun-2018 2:40 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

3140 of 5454





Chat now!